While GHK-Cu is generally well-tolerated in topical research, certain contraindications or precautions should be considered, especially for systemic research or in specific populations: Systemic Research: For systemic applications, GHK-Cu is generally not recommended for subjects who are pregnant, breastfeeding, have active cancer, or suffer from Wilsons disease (a condition involving copper accumulation)
Leyrat, J
View on PubMed Note: no published peer-reviewed study has tested CJC-1295 (No DAC) and Ipamorelin administered together, nor the stability of the two stored in a single reconstituted solution
Exposing to light breaks down the compounds
It may bypass combination with the R factor [haptocorrin] in the mouth or stomach. In contrast, Yamada et al
The first week of its second year of existence, however, has been a wild ride for most areas that have seen significant momentum - the GLP-1 Basket was no exclusion